Atlas Trials

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

Clinical trial NCT03609840 · COMPLETED

Trial details

NCT number
NCT03609840
Sponsor
University of California, San Francisco
Status
COMPLETED
Study type
OBSERVATIONAL
Hematologic MalignanciesNonmalignant DiseasesImmune DeficiencyHemoglobinopathiesGenetic Inborn Errors of MetabolismFanconi AnemiaThalassemiaSickle Cell Disease
Start date
2017-05-24
Primary completion
2023-07-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.